Biowaiver only for BCS I and – under certain conditions – BCS III drugs [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2020-07-16 11:27 (106 d 03:24 ago) – Posting: # 21710
Views: 766

Hi Steven,

THX! I was not aware of this one (should have searched my own guideline collection).

» https://www.ema.europa.eu/en/rivaroxaban-product-specific-bioequivalence-guidance

@dshah

BCS Classification  BCS Class: ☐ I  ☐ III   Neither of the two
                    Background: rivaroxaban may be considered a low solubility compound.

… is the end of the story.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,180 posts in 4,415 threads, 1,476 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Friday 13:51 CET (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5